| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Akari Therapeutics Plc (NASDAQ: AKTX)
AKTX Technical Analysis
5
| As on 9th Jun 2023 AKTX STOCK Price closed @ 0.16 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 1.07 & Strong Sell for SHORT-TERM with Stoploss of 1.41 we also expect STOCK to react on Following IMPORTANT LEVELS. |
AKTXSTOCK Price
| Open | 0.17 | Change | Price | % |
| High | 0.17 | 1 Day | 0.00 | 0.00 |
| Low | 0.14 | 1 Week | -0.03 | -15.79 |
| Close | 0.16 | 1 Month | -0.03 | -15.79 |
| Volume | 788239 | 1 Year | -1.37 | -89.54 |
| 52 Week High 1.59 | 52 Week Low 0.15 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| AKTX Daily Charts |
AKTX Intraday Charts |
Whats New @ Bazaartrend |
AKTX Free Analysis |
|
|
AKTX Important Levels Intraday
| RESISTANCE | 0.22 |
| RESISTANCE | 0.20 |
| RESISTANCE | 0.19 |
| RESISTANCE | 0.18 |
| SUPPORT | 0.14 |
| SUPPORT | 0.13 |
| SUPPORT | 0.12 |
| SUPPORT | 0.10 |
AKTX Forecast April 2024
| 4th UP Forecast | 0.62 |
| 3rd UP Forecast | 0.47 |
| 2nd UP Forecast | 0.38 |
| 1st UP Forecast | 0.29 |
| 1st DOWN Forecast | 0.03 |
| 2nd DOWN Forecast | -0.06 |
| 3rd DOWN Forecast | -0.15 |
| 4th DOWN Forecast | -0.3 |
AKTX Weekly Forecast
| 4th UP Forecast | 0.78 |
| 3rd UP Forecast | 0.58 |
| 2nd UP Forecast | 0.46 |
| 1st UP Forecast | 0.33 |
| 1st DOWN Forecast | -0.01 |
| 2nd DOWN Forecast | -0.14 |
| 3rd DOWN Forecast | -0.26 |
| 4th DOWN Forecast | -0.46 |
AKTX Forecast2024
| 4th UP Forecast | 3.05 |
| 3rd UP Forecast | 2.12 |
| 2nd UP Forecast | 1.55 |
| 1st UP Forecast | 0.98 |
| 1st DOWN Forecast | -0.66 |
| 2nd DOWN Forecast | -1.23 |
| 3rd DOWN Forecast | -1.8 |
| 4th DOWN Forecast | -2.73 |
Akari Therapeutics Plc ( NASDAQ USA Symbol : AKTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
AKTX Business Profile
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of treatments for autoinflammatory diseases that involve complement and leukotriene pathways. Its lead product candidate is nomacopan, a second-generation complement inhibitor that is in Phase II clinical trial for the treatment of autoimmune and inflammatory diseases, including paroxysmal nocturnal hemoglobinuria, guillain barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom. Address: 75/76 Wimpole Street, London, United Kingdom, W1G 9RT
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service